|
||||||
 |
Thimerosal Content in Some US Licensed Vaccines
February 23, 2010
|
Vaccine |
Brand Name (click on the brand name for package insert) |
Manufacturer |
Thimerosal Concentration1 |
Mercury |
|
|
Anthrax |
BioPort Corporation |
0 |
0 |
||
| DTaP | |||||
| Tripedia | sanofi pasteur | * | * | ||
|
GlaxoSmithKline |
0 |
0 |
|||
| DAPTACEL | sanofi pasteur |
0 |
0 |
||
| DTaP-HepB-IPV | Pediarix | GlaxoSmithKline | 0 | 0 | |
| DTaP-IPV-Hib | Pentacel | sanofi pasteur | 0 | 0 | |
| DTaP-Hib | TriHIBit | sanofi pasteur | * | * | |
|
DTwP |
All Products |
|
.01% |
25 |
|
|
DT |
multi-dose |
sanofi pasteur |
.01% |
25 |
|
| single dose | * | ||||
|
Td |
DECAVAC | sanofi pasteur | * | ||
|
sanofi pasteur |
|||||
|
Tdap |
ADACEL | sanofi pasteur | 0 | 0 | |
|
GlaxoSmithKline |
0 |
0 |
|||
|
Tetanus Toxoid |
sanofi pasteur |
.01% |
25 |
||
| Tetanus Toxoid Adsorbed Adult Use | .01% | 25 | |||
| Booster | .01% | 25 | |||
|
Hib |
sanofi pasteur |
0 |
0 |
||
| Hiberix | GlaxoSmithKline | 0 | 0 | ||
| HibTITER | Wyeth-Ayerst | 0 | 0 | ||
| PedvaxHIB liquid(2) | Merck | 0 | 0 | ||
| Hib/HepB | Comvax (3) | Merck | 0 | 0 | |
|
Hepatitis A |
GlaxoSmithKline |
0 |
0 |
||
| Vaqta adult/pediatric | Merck | 0 | 0 | ||
|
Hepatitis B |
Engerix-B preservative free |
GlaxoSmithKline |
0 |
0 |
|
| Recombivax HB preservative free | Merck | 0 | 0 | ||
|
Hep A-B |
GlaxoSmithKline |
0 |
0 |
||
|
HPV
|
GlaxoSmithKline |
0 | 0 | ||
|
Merck |
0 | 0 | |||
| Influenza 2009/10 Formula | Afluria | multi-dose | CSL Limited | .01% | 24.5 |
| single dose | 0 | 0 | |||
| Agriflu | Novartis | 0 | 0 | ||
| Fluarix | GlaxoSmithKline | ≤1 | |||
| FluLaval | GlaxoSmithKline | .01% | 25 | ||
| FluMist | MedImmune | 0 | 0 | ||
| Fluvirin | Novartis | .01% | 24.5 | ||
| Fluzone | 5 mL vial | sanofi pasteur | .01% | 25 | |
| No Preservative | 0 | 0 | |||
|
Influenza A - H1N1 2009
|
multi-dose |
CSL Limited |
.01% |
24.5 |
|
| single dose |
0 |
0 |
|||
| multi-dose |
Novartis |
.01% |
25 |
||
| single dose |
|
≤1 |
|||
| multi-dose |
sanofi pasteur |
.01% |
25 |
||
| single dose (.25 & .5 mL) |
0 |
0 |
|||
| Influenza A (H1N1) 2009 Monovalent Vaccine multi-dose | GlaxoSmithKline |
.01% |
25 |
||
| Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal | MedImmune | 0 | 0 | ||
|
IPV |
sanofi pasteur |
0 |
0 |
||
| Japanese Encephalitis | Intercell Biomedical |
0 |
0 |
||
| JE-Vax | sanofi pasteur | 0.007% | |||
|
Meningococcal |
Menactra | sanofi pasteur |
0 |
0 |
|
| multi-dose |
sanofi pasteur |
.01% |
25 |
||
| single dose |
0 |
0 |
|||
| Meveo | Novartis |
0 |
0 |
||
|
MMR |
Merck |
0 |
0 |
||
| MMR-Varicella | ProQuad | Merck | 0 | 0 | |
| Polio | IPOL | sanofi pasteur | 0 | 0 | |
|
Pneumococcal |
Wyeth-Ayerst |
0 |
0 |
||
|
Pneumovax 23 |
Merck | 0 | 0 | ||
|
Rabies |
|||||
| RabAvert | Chiron | 0 | 0 | ||
| sanofi pasteur | 0 | 0 | |||
|
Rotavirus |
RotaTeq | Merck | 0 | 0 | |
| Typhoid Fever |
sanofi pasteur |
0 |
0 |
||
| Vivotif | Berna Biotch | 0 | 0 | ||
|
Varicella Zoster
|
Merck |
0 |
0 |
||
|
Merck |
0 |
0 |
|||
|
Yellow Fever |
sanofi pasteur |
0 |
0 |
||
|
1. A
concentration of 1:10,000 is equivalent to a 0.01%
concentration. Thimerosal is approximately 50% Hg by weight.
A 1:10,000 concentration contains 25 micrograms of Hg per
0.5 mL. 2. A previously marketed lyophilized preparation contained 0.005% thimerosal. 3. COMVAX is not approved for use under 6 weeks of age because of decreased response to the Hib component. * This product should be considered equivalent to thimerosal-free products. This vaccine may contain trace amounts (<0.3 mcg) of mercury left after post-production thimerosal removal; these amounts have no biological effect. JAMA 1999;282(18) and JAMA 2000;283(16). |
|||||
|
This page was last updated on February 23, 2010 © 1999-2010 Institute for Vaccine Safety
|
